Chapter 18
Chapter 18
Julian Little,
Julian Little
Department of Epidemiology and Community Medicine, Canada Research Chair in Human Genome Epidemiology, University of Ottawa, Ottawa, ON Canada
Search for more papers by this authorJulian Little,
Julian Little
Department of Epidemiology and Community Medicine, Canada Research Chair in Human Genome Epidemiology, University of Ottawa, Ottawa, ON Canada
Search for more papers by this authorBook Editor(s):David Moher,
Douglas G. Altman,
Kenneth F. Schulz,
Iveta Simera,
Elizabeth Wager,
David Moher
Ottawa Hospital Research Institute and University of Ottawa, Ottawa, Canada
Search for more papers by this authorDouglas G. Altman
Centre for Statistics in Medicine, University of Oxford and EQUATOR Network, Oxford, UK
Search for more papers by this authorKenneth F. Schulz
FHI360, Durham, and UNC School of Medicine, Chapel Hill, North Carolina, USA
Search for more papers by this authorIveta Simera
Centre for Statistics in Medicine, University of Oxford and EQUATOR Network Oxford, UK
Search for more papers by this authorFirst published: 25 July 2014
Summary
The Strengthening the Reporting of Genetic Association Health Studies (STREGA) statement is a guideline for authors reporting genetic association studies. Genetic-risk prediction studies (GRIPS) typically concern the development and/or the evaluation of models for the prediction of a specific health outcome. The strategy followed in developing the GRIPS guidelines was consistent with recommendations proposed on how to develop health research reporting guidelines, which was published after the workshop. Systematic reviews and meta-analyses typically deal with one or a few variants of one or a few genes. The STREGA guideline is intended to maximize the transparency, quality, and completeness of reporting of what was done and found in a particular study. A multidisciplinary group developed the STREGA statement by using literature review, workshop presentations and discussion, and iterative electronic correspondence after the workshop.
References
- Lin, B.K., Clyne, M., Walsh, M. et al. (2006) Tracking the epidemiology of human genes in the literature: the HuGE Published Literature Database. American Journal of Epidemiology, 164, 1–4.
- Yu, Y., Yesupriya, A., Clyne, M. et al. HuGE Literature Finder. HuGE Navigator. Available from http://www.hugenavigator.net/HuGENavigator/startPagePubLit.do [accessed on 26 October 2010].
- Little, J., Khoury, M.J., Bradley, L. et al. (2003) The human genome project is complete. How do we develop a handle for the pump? American Journal of Epidemiology, 157, 667–673.
- Ioannidis, J.P., Bernstein, J., Boffetta, P. et al. (2005) A network of investigator networks in human genome epidemiology. American Journal of Epidemiology, 162, 302–304.
- Ioannidis, J.P., Gwinn, M., Little, J. et al. (2006) A road map for efficient and reliable human genome epidemiology. Nature Genetics, 38, 3–5.
- von Elm, E. & Egger, M. (2004) The scandal of poor epidemiological research. BMJ, 329, 868–869.
- Yesupriya, A., Evangelou, E., Kavvoura, F.K., et al. (2008) Reporting of human genome epidemiology (HuGE) association studies: an empirical assessment. BMC Medical Research Methodology, 8, 31.
- Aljasir, B., Ioannidis, J.P., Yurkiewich, A. et al. (2013) Assessment of systematic effects of methodological characteristics on candidate genetic associations. Human Genetics, 132, 167–178.
- Vandenbroucke, J.P., von Elm, E., Altman, D.G. et al. (2007) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Annals of Internal Medicine, 147, W163–W194.
- Daly, A.K. (2003) Candidate gene case-control studies. Pharmacogenomics, 4, 127–139.
- Siontis, K.C., Patsopoulos, N.A. & Ioannidis, J.P. (2010) Replication of past candidate loci for common diseases and phenotypes in 100 genome-wide association studies. European Journal of Human Genetics, 18, 832–837.
- McCarthy, M.I., Abecasis, G.R., Cardon, L.R. et al. (2008) Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nature Reviews Genetics, 9, 356–369.
- Pearson, T.A. & Manolio, T.A. (2008) How to interpret a genome-wide association study. JAMA, 299, 1335–1344.
- Hindorff, L.A., Junkins, H.A., Hall, P.N. et al. A catalog of published genome-wide association studies. Available from www.genome.gov/gwastudies [accessed on 20 October 2010].
- Chu, A.Y., Parekh, R.S., Astor, B.C. et al. (2009) Association of APOE polymorphism with chronic kidney disease in a nationally representative sample: a Third National Health and Nutrition Examination Survey (NHANES III) Genetic Study. BMC Medical Genetics, 10, 108.
- Crawford, D.C., Sanders, C.L., Qin, X. et al. (2006) Genetic variation is associated with C-reactive protein levels in the Third National Health and Nutrition Examination Survey. Circulation, 114, 2458–2465.
- Keebler, M.E., Sanders, C.L., Surti, A. et al. (2009) Association of blood lipids with common DNA sequence variants at 19 genetic loci in the multiethnic United States National Health and Nutrition Examination Survey III. Circulation Cardiovascular Genetics, 2, 238–243.
- Myers, R.H., Schaefer, E.J., Wilson, P.W. et al. (1996) Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study. Neurology, 46, 673–677.
- Slooter, A.J., Cruts, M., Kalmijn, S. et al. (1998) Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Archives of Neurology, 55, 964–968.
- Tang, M.X., Stern, Y., Marder, K. et al. (1998) The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA, 279, 751–755.
- Hivert, M.F., Manning, A.K., McAteer, J.B. et al. (2009) Association of variants in RETN with plasma resistin levels and diabetes-related traits in the Framingham Offspring Study. Diabetes, 58, 750–756.
- Little, J., Higgins, J.P., Ioannidis, J.P. et al. (2009) STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Medicine, 6, e22.
- Little, J., Higgins, J.P., Ioannidis, J.P. et al. (2010) STrengthening the REporting of Genetic Association studies (STREGA)—an extension of the STROBE statement. In: M.J. Khoury, S.R. Bedrosian, M. Gwinn, et al. (eds), Human Genome Epidemiology. Building the Evidence for Using Genetic Information to Improve Health and Prevent Disease, 2nd. edn., pp. 188–214, Oxford University Press, New York.
- Janssens, A.C., Ioannidis, J.P., van Duijn, C.M. et al. (2011) Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. BMJ, 342, d631.
-
Janssens, A.C., Ioannidis, J.P., Bedrosian, S. et al. (2011) Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): explanation and elaboration. Journal of Clinical Epidemiology, 64, e1–e22.
10.1016/j.jclinepi.2011.02.003 Google Scholar
- McShane, L.M., Altman, D.G., Sauerbrei, W. et al. (2005) Reporting recommendations for tumor marker prognostic studies (REMARK). Journal of the National Cancer Institute, 97, 1180–1184.
- Bossuyt, P.M., Reitsma, J.B., Bruns, D.E. et al. (2003) Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD Initiative. Annals of Internal Medicine, 138, 40–44.
- Bossuyt, P.M., Reitsma, J.B., Bruns, D.E. et al. (2003) The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Annals of Internal Medicine, 138, W1–W12.
- Moher, D., Schulz, K.F., Simera, I. & Altman, D.G. (2010) Guidance for developers of health research reporting guidelines. PLoS Medicine, 7, e1000217. [PMID: 20169112].
- Little, J., & Higgins, J.P.T. The HuGENet™ HuGE Review Handbook, version 1.0. Available from http://www.med.uottawa.ca/public-health-genomics/web/assets/documents/HuGE_Review_Handbook_V1_0.pdf [accessed on 20 July 2011].
- Higgins, J.P., Little, J., Ioannidis, J.P. et al. (2007) Turning the pump handle: evolving methods for integrating the evidence on gene-disease association. American Journal of Epidemiology, 166, 863–866.
- Ioannidis, J.P., Boffetta, P., Little, J. et al. (2008) Assessment of cumulative evidence on genetic associations: interim guidelines. International Journal of Epidemiology, 37, 120–132.
- Khoury, M.J., Bertram, L., Boffetta, P. et al. (2009) Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases. American Journal of Epidemiology, 170, 269–279.
- Bertram, L., McQueen, M.B., Mullin, K. et al. (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nature Genetics, 39, 17–23.
- Theodoratou, E., Montazeri, Z., Hawken, S. et al. (2012) Systematic meta-analyses and field synopsis of genetic association studies in colorectal cancer. Journal of the National Cancer Institute, 104, 1433–1457.
- Boffetta, P., Winn, D.M., Ioannidis, J.P. et al. (2012) Recommendations and proposed guidelines for assessing the cumulative evidence on joint effects of genes and environments on cancer occurrence in humans. International Journal of Epidemiology, 41, 686–704.
- Davidoff, F., Batalden, P., Stevens, D. et al. (2008) Publication guidelines for improvement studies in health care: evolution of the SQUIRE Project. Annals of Internal Medicine, 149, 670–676.
- Marcus, E. (2009) Taming supplemental material. Cell, 139, 11.
- Marcus, E. (2010) 2010: a Publishing Odyssey. Cell, 140, 9.
- Altman, D.G., Schulz, K.F., Moher, D. et al. (2001) The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Annals of Internal Medicine, 134, 663–694.
- Moher, D., Schultz, K.F. & Altman, D. (2001) The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA, 285, 1987–1991.
- Burton, P.R., Hansell, A.L., Fortier, I. et al. (2009) Size matters: just how big is BIG?: Quantifying realistic sample size requirements for human genome epidemiology. International Journal of Epidemiology, 38, 263–273.
- Knoppers, B.M., Fortier, I., Legault, D. & Burton, P. (2008) The Public Population Project in Genomics (P3G): a proof of concept? European Journal of Human Genetics, 16, 664–665.
- Stover, P.J., Harlan, W.R., Hammond, J.A. et al. (2010) PhenX: a toolkit for interdisciplinary genetics research. Current Opinion in Lipidology, 21, 136–140.
- Fortier, I., Burton, P.R., Robson, P.J. et al. (2010) Quality, quantity and harmony: the DataSHaPER approach to integrating data across bioclinical studies. International Journal of Epidemiology. 39, 1383–1393.
- Cordell, H.J. (2009) Detecting gene-gene interactions that underlie human diseases. Nature Reviews Genetics, 10, 392–404.
- Thomas, D. (2010) Methods for investigating gene-environment interactions in candidate pathway and genome-wide association studies. Annual Review of Public Health, 31, 21–36.
- Wain, L.V., Armour, J.A. & Tobin, M.D. (2009) Genomic copy number variation, human health, and disease. Lancet, 374, 340–350.
- Tucker, T., Marra, M. & Friedman, J.M. (2009) Massively parallel sequencing: the next big thing in genetic medicine. American Journal of Human Genetics, 85, 142–154.
- Astle, W. & Balding, D.J. (2009) Population structure and cryptic relatedness in genetic association studies. Statistical Science, 24, 451–471.
- Dadd, T., Weale, M.E. & Lewis, C.M. (2009) A critical evaluation of genomic control methods for genetic association studies. Genetic Epidemiology, 33, 290–298.
- Price, A.L., Zaitlen, N.A., Reich, D. & Patterson, N. (2010) New approaches to population stratification in genome-wide association studies. Nature Reviews Genetics, 11, 459–463.
- Minelli, C., Thompson, J.R., Abrams, K.R. et al. (2008) How should we use information about HWE in the meta-analyses of genetic association studies? International Journal of Epidemiology, 37, 136–146.
- Yurkiewich, A.J., (2011) An analysis of genome-wide association studies to produce evidence useful in guiding their reporting and synthesis. MSc thesis, University of Ottawa, Ottawa, ON, Canada, 1–181.
